Critical illness (CI) has finally succumbed to the slump that has been blighting the protection market. But resurrecting the product may be an issue of reinvention as Peter Madigan discovers Click here to download pdf
In a protection market that has looked pretty bleak in the last few years, critical illness (CI) insurance has been one of the few success stories. In the 20 years since its creation, the product has established itself as a market leader that had seemed impervious to the slump that has struck its stable mate, income protection (IP). It now appears however, that its good run is over and following a drop in sales in 2003, it appears the product is now in full-blown decline. Perhaps the most worrying fact about the situation is the speed with which CI's fortunes have turned. With the same swi...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes